- Home
- CLRB vs SDSTW Comparison
CLRB vs SDSTW Comparison
Compare CLRB & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLRB | SDSTW |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | 8 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 13.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CLRB | SDSTW |
|---|---|---|
| Price | $3.32 | $0.29 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.5K | ★ 41.6K |
| Earning Date | 03-12-2026 | 03-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.45 | $0.10 |
| 52 Week High | $20.60 | $0.12 |
Technical Indicators
Market Signals| Indicator | CLRB | SDSTW |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 69.14 |
| Support Level | $3.14 | $0.20 |
| Resistance Level | $3.42 | $0.29 |
| Average True Range (ATR) | 0.21 | 0.03 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 56.06 | 98.39 |
Price Performance
Historical ComparisonAbout CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).